Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000908401-02-000002
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
3
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 BODY OF 10-K FOR GBL 12/31/01 glyko10kver6clean.txt 10-K 204301
3 PROJECT CURE AGREEMENT exhibit_10-27.txt EX-2 229324
4 AUDIT RELATED LETTER lettertosec.txt EX-99 1133
  Complete submission text file 0000908401-02-000002.txt   436501
Mailing Address ATTENTION: CONTROLLER 11 PIMENTEL COURT NOVATO CA 94949
Business Address ATTENTION: CONTROLLER 11 PIMENTEL COURT NOVATO CA 94949 415-884-6725
GLYKO BIOMEDICAL LTD (Filer) CIK: 0000908401 (see all company filings)

EIN.: 680230537 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21994 | Film No.: 02598726
SIC: 2835 In Vitro & In Vivo Diagnostic Substances